NEWS
2020.10.14
Rebirthel concluded the research collaboration agreement with Fujita Health University. – Joint development of the therapy for the novel coronavirus infection using universal killer T cells –
Rebirthel concluded an agreement to collaborate with Fujita Health University to develop a new ...
Media , NEWS
2020.10.2
The research license agreement between Rebirthel and Otsuka Pharmaceutical was reported on Kyoto Shimbun (Japanese newspaper).
In the morning edition of Kyoto Shimbun on October 2nd, 2020 (Economy section, Page 11), the co...
NEWS
2020.10.1
Rebirthel concluded the research license agreement with Otsuka Pharmaceutical.
Rebirthel concluded the research license agreement with Otsuka Pharmaceutical on October 1st, 2...
NEWS
2020.8.5
Professor Hiroshi Kawamoto’s research was featured on Yomiuri Shimbun (Japanese newspaper).
In the evening edition of Yomiuri Shimbun on August 5th, 2020 (Page 10), a research activity of...
NEWS
2020.4.9
Introduction
The world is presently facing the serious situation of the coronavirus pandemic. We all need to...